Skip to main content
. 2022 Mar 29;6:133–141. doi: 10.5414/ALX02299E

Table 3. Classification of all subjects (n = 48) based on mold sensitization (mx1-sIgE ≥ 0.35 kUA/L).

Whole blood assay study group (n = 48)
Mold sensitized (mx1)
(n = 12)
Non-mold sensitized
(n = 36)
Male: n (%) 10 (83) 14 (39)
Age (years): median (range) 52 (23 – 65) 46 (22 – 75)
≥ 50 years: n (%) 7 (58) 14 (39)
Smoker: n (%) 2 (17) 6 (50)
Respiratory symptoms: n (%) 12 (100) 23 (64)
Asthma: n (%) 12 (100) 13 (36)
Mold-exposed: n (%) 10 (83) 19 (53)
sx1-positive: n (%) 11 (92) 15 (42)